Kezar Life Sciences Inc. (KZR)

NASDAQ: KZR · Real-Time Price · USD

4.48

0.08 (1.82%)

At close: May 02, 2025, 12:48 PM

Kezar Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	7M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	1.07M	1.02M	1.51M	1.54M	1.3M	690K	175K	154K
Gross Profit	n/a	5.93M	-1.02M	-1.51M	-1.54M	-1.3M	-690K	-175K	-154K
Operating Income	-90.61M	-105.24M	-71.16M	-54.66M	-42.95M	-37.34M	-24.73M	-8.75M	-8.99M
Interest Income	8.46M	11.1M	4.11M	188K	1.21M	2.25M	1.56M	232K	n/a
Pretax Income	-83.74M	-101.87M	-68.24M	-54.63M	-41.74M	-35.09M	-23.17M	-8.52M	-8.99M
Net Income	-83.74M	-101.87M	-65.32M	-53.28M	-38.99M	-31.53M	-23.17M	-8.52M	-8.99M
Selling & General & Admin	23.39M	26.54M	20.15M	15.72M	11.97M	9.98M	6.59M	2.28M	1.62M
Research & Development	65.74M	85.7M	51.01M	38.94M	30.98M	27.36M	18.14M	6.47M	7.37M
Other Expenses	1.47M	6.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	90.61M	118.42M	71.16M	54.66M	42.95M	37.34M	24.73M	8.75M	8.99M
Interest Expense	-1.59M	1.55M	1.19M	159K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	112.24M	71.16M	54.66M	42.95M	37.34M	24.73M	8.75M	8.99M
Income Tax Expense	n/a	n/a	-2.92M	-1.35M	-2.75M	-3.56M	1.56M	n/a	n/a
Shares Outstanding (Basic)	72.9M	72.55M	67.37M	52.76M	44M	19.08M	10.26M	13.02M	13.02M
Shares Outstanding (Diluted)	72.9M	72.55M	67.37M	52.76M	44M	19.08M	10.26M	13.02M	13.02M
EPS (Basic)	-1.15	-1.4	-0.97	-1.01	-0.89	-1.65	-2.26	-0.65	-0.69
EPS (Diluted)	-1.15	-1.4	-0.97	-1.01	-0.89	-1.65	-2.26	-0.65	-0.69
EBITDA	-90.61M	-99.25M	-66.11M	-52.96M	-40.26M	-34.42M	-22.48M	-8.34M	-8.84M
EBIT	-85.33M	-100.32M	-67.13M	-54.47M	-41.8M	-35.72M	-23.17M	-8.52M	-8.99M
Depreciation & Amortization	-5.28M	1.07M	1.02M	1.51M	1.54M	1.3M	690K	175K	154K